Planta Medica Letters 2016; 3(01): e17-e19
DOI: 10.1055/s-0042-102460
Letter
Georg Thieme Verlag KG Stuttgart · New York

Miconidin Acetate and Primin as Potent 5-Lipoxygenase Inhibitors from Brazilian Eugenia hiemalis (Myrtaceae)

Gabriele Andressa Zatelli
1   Laboratory of Natural Products, Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianopolis, Brazil
,
Veronika Temml
2   Institute of Pharmacy/Pharmacognosy, Institute of Pharmacy and Center for Molecular Biosciences Innsbruck (CMBI), Innsbruck, Austria
,
Zsofia Kutil
3   Laboratory of Plant Biotechnologies, Institute of Experimental Botany AS CR, v. v. i., Prague, Czech Republic
,
Premysl Landa
3   Laboratory of Plant Biotechnologies, Institute of Experimental Botany AS CR, v. v. i., Prague, Czech Republic
,
Tomas Vanek
3   Laboratory of Plant Biotechnologies, Institute of Experimental Botany AS CR, v. v. i., Prague, Czech Republic
,
Daniela Schuster
4   Computer-Aided Molecular Design Group, Institute of Pharmaceutical Chemistry, and Center for Molecular Biosciences Innsbruck (CMBI), Innsbruck, Austria
,
Miriam Falkenberg
1   Laboratory of Natural Products, Department of Pharmaceutical Sciences, Federal University of Santa Catarina, Florianopolis, Brazil
› Institutsangaben
Weitere Informationen

Publikationsverlauf

received 24. September 2015
revised 24. Dezember 2015

accepted 24. Januar 2016

Publikationsdatum:
14. März 2016 (online)

Abstract

This paper describes the isolation and identification of primin and miconidin acetate as metabolites from the flower bud extract of Eugenia hiemalis as well as the anti-inflammatory activity of miconidin acetate by inhibition of 5-lipoxygenase. Miconidin acetate inhibited leukotriene B4 formation catalyzed by the human recombinant enzyme (IC50 = 0.3 ± 0.17 µM) more than primin (IC50 = 1.4 ± 0.6 µM) and zileuton (IC50 = 1.1 ± 0.7 µM). Miconidin acetate (20 µM) inhibited LTB4 formation to an extent of 59 ± 12 % in vitro using a cell-based assay, comparable to the positive control zileuton (69 ± 12 % inhibition at a concentration of 10 µM). The binding modes of miconidin acetate were further evaluated in silico by molecular docking to the human 5-lipoxygenase crystal structure. The hydroxyl group was predicted to form a hydrogen bond with the terminal Ile676, while the pentyl moiety occupied the hydrophobic substrate channel. The obtained results show that flower buds of E. hiemalis are an interesting source of anti-inflammatory compounds, mainly of miconidin acetate.

Supporting Information

 
  • References

  • 1 Govaerts R, Sobral M, Ashton P, Barrie F, Holst BK, Landrum LR, Matsumoto K, Mazine FF, Lughadha EN, Proneça C, Soares-Silva LH, Wilson PG, Lucas E. World checklist of Myrtaceae. London: Kew Royal Botanic Gardens Publishing; 2008
  • 2 Landrum LR, Kawasaki ML. The genera of Myrtaceae in Brazil: an illustrated synoptic treatment and identification Keys. Brittonia 1997; 49: 508-536
  • 3 Flores G, Dastmalchi K, Paulino S, Whalen K, Dabo AJ, Reynertson KA, Foronjy RF, DʼArmiento JM, Kennelly EJ. Anthocyanins from Eugenia brasiliensis edible fruits as potential therapeutics for COPD treatment. Food Chem 2012; 134: 1256-1262
  • 4 Cole RA, Haber WA, Setzer AN. Chemical composition of essential oils of seven species of Eugenia from Monteverde, Costa Rica. Biochem Syst Ecol 2007; 35: 877-886
  • 5 Slowing K, Carretero E, Villar A. Anti-inflammatory activity of leaf extracts of Eugenia jambos in rats. J Ethnopharmacol 1994; 43: 9-11
  • 6 Ferro E, Schinini A, Maldonado M, Rosner J, Hirschmann GS. Eugenia uniflora leaf extract and lipid metabolism in Cebus apella monkeys. J Ethnopharmacol 1988; 24: 321-325
  • 7 Souza GC, Haas APS, von Poser GL, Schapoval EES, Elisabetsky E. Ethnopharmacological studies of antimicrobial remedies in the south of Brazil. J Ethnopharmacol 2004; 90: 135-143
  • 8 Kawasaki ML. Flora da Serra do Cipó, Minas Gerais, Myrtaceae. Bolm Botânica Univ S Paulo 1989; 11: 121-170
  • 9 Falkenberg MB. Quinones and other metabolites from Eugenia hiemalis Cambessèdes and Paramyrciaria glazioviana (Kiaerskou) Sobral (Myrtaceae) [thesis]. Bonn: University of Bonn; 1996
  • 10 Efferth T, Rücker G, Falkenberg M, Manns D, Olbrich A, Fabry U, Osieka R. Detection of apoptosis in KG-1a leukemic cells treated with investigational drugs. Arzneimittelforschung 1996; 46: 196-200
  • 11 Bokesch HR, Wamiru A, Le Grice SFJ, Beutler JA, McKee TC, McMahon JB. HIV-1 ribonuclease H inhibitory phenolic glycosides from Eugenia hyemalis . J Nat Prod 2008; 71: 1634-1636
  • 12 Zatelli GA, Zimath P, Tenfen A, Cordova CMM, Scharf DR, Simionatto EL, Alberton MD, Falkenberg M. Antimycoplasmic activity and seasonal variation of essential oil of Eugenia hiemalis Cambess. (Myrtaceae). Nat Prod Res DOI: 10.1080/14786419.2015.1091455. advance online publication 1 October 2015
  • 13 Apel MA, Sobral M, Schapoval ES, Henriques AT, Menut C, Bessiere JM. Chemical composition of the essential oils of Eugenia hyemalis and Eugenia stigmatosa. Part VI: section biflore. J Essent Oil Res 2004; 16: 437-439
  • 14 Gautam R, Jachak SM. Recent developments in anti-inflammatory natural products. Med Res Rev 2009; 29: 767-820
  • 15 Landa P, Kutil Z, Temml V, Vuorinen A, Malik J, Dvorakova M, Marsik P, Kokoska L, Pribylova M, Schuster D, Vanek T. Redox and non-redox mechanism of in vitro cyclooxygenase inhibition by natural quinones. Planta Med 2012; 78: 326-333
  • 16 Landa P, Kutil Z, Temml V, Malik J, Kokoska L, Widowitz U, Pribylova M, Dvorakova M, Marsik P, Schuster D, Bauer R, Vanek T. Inhibition of in vitro leukotriene B4 biosynthesis in human neutrophil granulocytes and docking studies of natural quinones. Nat Prod Commun 2013; 8: 105-108
  • 17 Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK. Relating protein pharmacology by ligand chemistry. Nat Biotechnol 2007; 25: 197-206
  • 18 Keiser MJ, Roth BL, Armbruster BN, Ernsberger P, Irwin JJ, Shoichet BK. SEA. Available at. http://sea.bkslab.org Accessed February 17, 2016
  • 19 Lounkine E, Keiser MJ, Whitebread S, Mikhailov D, Hamon J, Jenkins JL, Lavan P, Weber E, Doak AK, Côté S, Shoichet BK, Urban L. Large-scale prediction and testing of drug activity on side-effect targets. Nature 2012; 486: 361-367
  • 20 Adams M, Kunert O, Haslinger E, Bauer R. Inhibition of leukotriene biosynthesis by quinolone alkaloids from the fruits of Evodia rutaecarpa . Planta Med 2004; 70: 904-908
  • 21 Werz O, Steinhilber D. Development of 5-lipoxygenase inhibitors-lessons from cellular enzyme regulation. Biochem Pharmacol 2005; 70: 327-333
  • 22 Gilbert NC, Bartlett SG, Waight MT, Neau DB, Boeglin WE, Brash AR, Newocomer ME. The structure of human 5-lipoxygenase. Science 2011; 14: 217-219
  • 23 Connolly M, Cune JM, Dauncey E, Lovell CR. Primula obconica – is contact allergy on the decline?. Contact Dermatitis 2004; 51: 167-171
  • 24 Krebs M, Christensen LP. 2-methoxy-6-pentyl-1,4-dihydroxybenzene (miconidin) from Primula obconica: a possible allergen?. Contact Dermatitis 1995; 33: 90-93
  • 25 Horper W, Marner F. Phenols and quinones from leaves of Primula obconica . Nat Prod Lett 1995; 6: 163-170
  • 26 Albert D, Zündorf I, Dingermann T, Müller WE, Steinhilber D, Werz O. Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. Biochem Pharmacol 2002; 64: 1767-1775